Economy

Novartis acquires British start-up Myricx Bio

Novartis acquires a British laboratory at the preclinical stage

This content was published on Jul 6, 2026 The Swiss pharma giant will pay $1.1 billion (CHF883 million) to acquire Myricx Bio, which is developing antibody-drug conjugates for various types of solid tumours.

New treatments

How a Swiss lab is finding new cures in old drugs

This content was published on Jul 6, 2026 Geneva researchers are repurposing existing drugs for rare diseases, offering new hope where options are scarce.

The Food Initiative Committee launches its campaign

Food safety

Proponents of food security initiative launch campaign

This content was published on Jul 2, 2026 The committee behind a people’s initiative for safe food and clean drinking water is calling for changes to Swiss agricultural policy.

More and more people in Switzerland are falling ill as a result of food

Food safety

Number of foodborne illnesses up slightly in Switzerland

This content was published on Jul 2, 2026 In Switzerland in 2025, campylobacteriosis was the most common foodborne infection, followed by salmonellosis.

Roche claims clinical success for a cancer drug

New treatments

Roche claims clinical trial success for lung cancer drug

This content was published on Jul 2, 2026 Swiss pharmaceutical and diagnostics giant Roche announced the success of a pivotal clinical trial for its drug divarasib in the treatment of a form of lung cancer.

Lonza is expanding its partnership with a US client

Healthcare innovation

Swiss pharma firm Lonza expands partnership with US client

This content was published on Jul 1, 2026 Lonza is expanding its collaboration with an American biopharmaceutical company, the identity of which has not been disclosed.

Agribusiness

Basel-based Chinese agribusiness firm Syngenta names new CEO

This content was published on Jul 1, 2026 Syngenta names Hengde Qin as CEO from August 1 as Jeff Rowe returns to the US, while IPO plans continue.

New treatments

A mother’s quest to find a cure for her son

This content was published on Jun 30, 2026 The story of how one mother is uniting families and researchers around the world to find a cure for her son's rare disease.

Food supply chains

‘We want Orior to strengthen its position in the world of premium food’

This content was published on Jun 27, 2026 Monika Walser, currently at the helm of Swiss food and beverage group Orior, says building international food brands is challenging.

Healthcare innovation

Japanese SoftBank acquires robotics arm of ABB to create super AI

This content was published on Jun 25, 2026 The Swiss M&A market reached record levels in 2025. Swissinfo looks at some of those deals and why they matter.

Page 13 of 51

First … 11 12 13 14 15 … Last

Economy

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Economy

More

Novartis acquires British start-up Myricx Bio

More

How a Swiss lab is finding new cures in old drugs

More

Proponents of food security initiative launch campaign

More

Number of foodborne illnesses up slightly in Switzerland

More

Roche claims clinical trial success for lung cancer drug

More

Swiss pharma firm Lonza expands partnership with US client

More

Basel-based Chinese agribusiness firm Syngenta names new CEO

More

A mother’s quest to find a cure for her son

More

‘We want Orior to strengthen its position in the world of premium food’

More

Japanese SoftBank acquires robotics arm of ABB to create super AI

Popular Stories

Most Discussed